One Sentence Summary: SRPK3 regulates alternative splicing of pre-mRNA that is crucial for B cell development, activation and antibody responses.
marrow (BM) and periphery suggest that the kinase is important for B cell signaling and antibody responses.
Here, we used B cell-specific conditionally deleted Srpk3 (Srpk3-cKO) mice to demonstrate that SRPK3 is essential for efficient development of immature and mature B cells in the BM.
Decreased generation of these cells correlates with extensive changes in AS events. Srpk3-cKO mice secrete reduced levels of antigen-specific IgG3 in response to the T lymphocyteindependent type 2 (TI-2) antigen 4-hydroxy-3-nitrophenylacetyl-Ficoll (NP-Ficoll). We confirmed that this phenotype is due to the impairment of marginal zone (MZ) B cells, which also exhibit changes in AS in the absence of SRPK3. Overall, loss of SRPK3 profoundly affects B cell development and cellular metabolism including mitochondrial biogenesis and function necessary for normal immune responses of B cells.
Results

Deletion of Srpk3 in vivo results in decreased immature and mature BM B cells
To assess the physiological roles of SRPK3 in B cell development in vivo, we bred Srpk3-floxed female (Srpk3 fl/fl ) or male (Srpk3 fl/y ) mice with CD79aCre Tg/+ mice that express Cre recombinase in early B cell progenitors (21, 22) . Deletion of Srpk3 floxed alleles results in loss of exons 6-8, which encode functional kinase residues (Fig. S1A ). In resulting Srpk3 conditional knockout (Srpk3 cKO/cKO females or Srpk3 cKO/y males; collectively Srpk3-cKO) mice, Cre-mediated deletion initiates in early pre-pro B cells prior to expression of Srpk3 (Fig. S1 B-D) .
To characterize phenotypic differences in BM B cell progenitors lacking SRPK3, we used flow cytometry to determine relative frequencies of cells in BM of wild-type (WT) and Srpk3-cKO male and female mice (23) . In Srpk3-cKO BM, early stages of B cell development are unaffected, while later stage immature and mature B cells are decreased ( Fig. 1 , A-E). In contrast, we observed no differences between splenic B cell populations of WT and Srpk3-cKO mice (Fig. S2 , A-E).
The decrease in immature BM B cell numbers in Srpk3-cKO mice could be due to impairment of Ig light chain gene rearrangements. Using flow cytometry, we observed that Srpk3-cKO immature and mature B cells have increased ratios of k/l light chains relative to WT cells ( Fig. 2 , A-D). Splenic B cells also show this trend (Fig. S3, A and B ). No significant differences were detected between frequencies of intracellular k + cells or k mean fluorescence intensity (MFI) in Srpk3-cKO versus WT pre-B cells (Fig. S4, A and B ). Thus, SRPK3 is important for the generation of normal BCR repertoires in mice.
SRPK3 regulates patterns of AS in immature and mature BM B cells
Srpk3 expression is highest in immature B cells during B lymphopoiesis (24) . Therefore, we hypothesized that SRPK3 regulates splicing of pre-mRNAs necessary to generate immature B cells, and/or for their selection in the BM. For comparison, we analyzed mRNAs isolated from mature BM B cells (25) . We performed RNA-seq to determine genome-wide changes in transcript frequencies and patterns of AS. Purity of sorted populations was assessed ( Fig. S5A) and principal component analysis (PCA) of RNA-seq was performed to determine relationships between biological replicates between populations ( Fig. S5B ). Differential gene expression (DGE) analysis identified only 5 differentially expressed genes between WT and Srpk3-cKO immature B cells, including Cd79a (due to the Cre knock-in allele) (³ 1.5 fold; Padj < 0.05).
Similarly, only 18 genes were differentially expressed between WT and Srpk3-cKO mature B cells, including Col5a3, which encodes a chains of fibrillar collagens that regulate metabolism in mice (26) , and Fms-tyrosine kinase 3 (Flt3) , which is essential for B cell maturation (27) (³ 1.5 fold, Padj < 0.05) (Data file S1). Analysis of AS events revealed robust changes in splicing patterns between mRNAs of WT and Srpk3-cKO immature and mature BM B cells. We detected 290 significant AS events in immature B cells and 620 significant AS events in mature B cells (DY ³ 0.1, FDR < 0.05) ( Fig. 3A; Fig. S6A ; Data file S2). In both immature and mature B cells, skipped exons (SE) comprised the majority of AS events, while differences in the inclusion of mutually exclusive exons (MXE) were the second most frequent type of AS. Other types of events, including alternative 3' splice sites (A3SS), alternative 5' splice sites (A5SS) and retained introns (RI) were detected at lower frequencies. When displayed in a heat map that separates WT from Srpk3-cKO AS events ( Additionally, IPA indicated that critical cellular pathways including ERK5, AMPK, mTOR and TGF-b signaling are affected by the loss of SRPK3 in mature B cells ( Fig. S6B ). In support of RNA-seq data we validated AS of genes that are strongly affected by the loss of SRPK3. AS of transcripts of Tyrosine kinase 2 (Tyk2), a component of type I and type III interferon signaling pathways that regulates mitochondrial function (28, 29) , and NIMA related kinase 4 (Nek4), which regulates DDR (30), were confirmed ( Fig.3 , C and D). We hypothesize that the combined dysregulation of crucial genes contributes to the decreased frequencies of immature and mature B cells in Srpk3-cKO mice.
The most direct way that SPRK3 can affect splicing is through its phosphorylation of SR proteins (31) . Analysis of the preferred RNA motifs and activities for many RNA binding proteins indicated that SR proteins generally bind the sequence 'GCAG' in pre-mRNAs (32) .
Binding of SR proteins to these motifs downstream of alternative exons can inhibit their inclusion in spliced transcripts. Therefore, we expect to observe an enrichment of GCAG motifs downstream of alternative exons that display increased inclusion in Srpk3-cKO B cells. We calculated GCAG motif density in regions surrounding alternative exons that were more or less included in Srpk3-cKO cells compared to WT ( Fig. 3E; Fig. S6C ). Motif densities in sequences surrounding these exons were compared to densities around control exons that were unaffected in Srpk3-cKO cells. As a further control, we also calculated densities for control motifs that had the same GC and CpG contents as GCAG.
In immature B cells, we observed that exons that were more included in Srpk3-cKO cells had a significant enrichment of GCAG motifs downstream of the alternative exon compared to exons whose splicing was unaffected ( Fig. 3E ). Conversely, we observed significantly lower frequencies of GCAG motifs following exons whose inclusion was decreased in Srpk3-cKO cells. These observations are consistent with splicing regulatory activities of SRPK3 and SR proteins in immature B cells. We did not observe a similar motif enrichment in the mature B cell data, perhaps due to different regulatory roles of SRPK3 in mature B cells ( Fig. S6C ).
SRPK3 is essential for TI-2 immune responses in vivo
Genetic database searches [MyGene2, (33) ; MARRVEL, (34)] yielded valuable information regarding known SRPK3 mutations and phenotypes, including immunodeficiency, associated with genetic variants in human patients. To confirm that SRPK3 deficiency attenuates immune function, we first investigated basal immunoglobulin levels in naïve mice. IgG1 serum levels were significantly elevated in naïve Srpk3-cKO mice, whereas IgG3 serum levels trended lower ( Fig. S7A ). To determine the impact of SRPK3-deficiency on immune responses in vivo, we immunized mice with NP-Lipopolysaccharide (LPS), a model TI-1 antigen, or NP-Ficoll, a model TI-2 antigen, and measured NP-specific IgM and IgG3 antibody responses. Similar levels of NP-specific IgM and IgG3 were detected between Srpk3-cKO and WT mice in response to NP-LPS (over 28 days post-immunization; Fig. S8A ). Anti-NP IgM levels were unaffected between Srpk3-cKO and WT mice after immunization with NP-Ficoll. However, Srpk3-cKO mice produced significantly reduced levels of NP-specific IgG3 over three weeks postimmunization ( Fig. 4, A and B ). Immunization was also performed with the model T lymphocyte-dependent (TD) antigen NP-chicken-gammaglobulin (NP-CGG), and NP-specific IgM and IgG1 titers were measured. Anti-NP IgM titers were decreased in Srpk3-cKO mice after initial challenge ( Fig. S8B ). Additionally, Srpk3-cKO mice generated increased levels of NPspecific IgG1 antibodies after primary immunization but failed to increase production after secondary immunization ( Fig. S8B ).
We hypothesized that the dysregulation of TI-2 antibody responses is due to defective generation or proliferation of NP-specific B cells in Srpk3-cKO mice. Indeed, we observed decreased frequencies and overall cell numbers of NP-specific IgM + and IgG3 + B cells in Srpk3-cKO mice 4 days after immunization with NP-Ficoll ( Fig. 4 , C-E). These data suggest that either NP-specific SRPK3-deficient B cells do not proliferate to the same extent as WT B cells in response to immunization or have fewer NP-specific B cells prior to immunization. We also considered whether reductions in NP-specific IgG3 + B cells are due to defective class switch recombination (CSR) in response to NP-Ficoll immunization (Fig. S9A ). Relative expression of transcripts associated with CSR indicated no significant differences between WT and Srpk3-cKO spleen B cells.
SRPK3 is required for MZ B cell responses to TI-2 antigens
Given that MZ B cells have been reported to be centrally important for TI-2 antibody responses (35) , we hypothesized that the inability of Srpk3-cKO mice to generate robust immune responses to NP-Ficoll is due, in part, to an intrinsic defect in MZ B cells. Therefore, we purified naïve MZ B cells from Srpk3-cKO and WT (all male) mice and stimulated them in vitro with dextranconjugated anti-IgD antibody (a-d-dex), which elicits TI-2 type BCR signaling, together with interleukin-5 (IL-5) and interferon-gamma (IFNg) to mimic the response to soluble TI-2 antigens in vivo (36, 37) . Initially, we measured IgM and IgG3 antibody secretion after 6 days in culture.
Srpk3-cKO MZ B cells produced significantly lower titers of both IgM and IgG3 compared to
WT cells (Fig. 5, A and B) . These data suggest that SRPK3 is crucial for MZ B cell responses to antigens in vitro. We next quantitated surface expression of BCR and cytokine receptors using flow cytometry. Srpk3-cKO naïve mice had significantly reduced IL-5Ra + MZ B cells (Fig. S10 , A and B). However, we found no relative differences between IgD or IFNg-receptor (IFNGR1) expression on MZ B cells from Srpk3-cKO versus WT unimmunized mice ( Fig. S10 , C-F). We next determined whether defective antibody production was due to failure of MZ B cells to proliferate, differentiate to ASCs, or undergo CSR. WT and Srpk3-cKO MZ B cell numbers increased similarly in response to activation and unstimulated cells were detected in comparable numbers after 3 days in vitro (Fig. S11A) . Thus, Srpk3-cKO MZ B cells proliferate normally in response to BCR stimulation and displayed similar in vitro half-life as WT. Next, cells were harvested and analyzed for differentiation to ASCs using CD138 and TACI as plasma cell markers (38, 39) . Both Srpk3-cKO and WT MZ B cells differentiated into ASCs similarly after 3 days in culture (Fig. S12, A and B) . To assess CSR, we analyzed germline and post-switch transcripts in naïve and stimulated cells. We detected no defects in the abilities of Srpk3-cKO MZ B cells to undergo CSR in response to activation (Fig. S13A) . These data indicate that Srpk3-cKO MZ B cells proliferate and differentiate normally but have additional underlying abnormalities that influence the ability of these cells to respond to antigen. We focused on naïve and 8-hour stimulated MZ B cells, because these conditions captured splicing changes before and after B cell activation. Moreover, RNA-seq confirmed that Srpk3 gene transcription shuts off between 8-and 72-hours of stimulation (Data file S3). IPA of differentially spliced genes identified several key cellular pathways that were enriched in WT versus Srpk3-cKO MZ B cells (Fig. 6, C and D) . In naïve cells, these pathways included purine metabolism, B cell development, estrogen biosynthesis and primary immunodeficiency signaling ( Fig. 6C) . In 8-hour stimulated cells, enriched pathways included cholesterol biosynthesis, triacylglycerol degradation and heparan sulfate biosynthesis (Fig. 6D) . Because a majority of these pathways were related to cell metabolism, we addressed the hypothesis that differential splicing of genes in Srpk3-cKO MZ B cells impairs metabolic function. In naïve cells, validation was obtained for AS of Solute carrier family 1 member 5 (Slc1a5), a neutral amino acid transporter of glutamine (40) , and Mitochondrial elongation factor 1 (Mief1; independently identified as MiD51), which regulates mitochondrial fusion (41) (Fig. 6 , E and F). In 8-hour stimulated samples, Nicotinamide nucleotide transhydrogenase (Nnt), an inner mitochondrial membrane protein that contributes to mitochondrial NADPH/NADP + ratios (42) and
SRPK3 modulates alternative splicing patterns in naïve and stimulated MZ B cells
Mitochondrial elongation factor 2 (Mief2; independently identified as MiD49), a mitochondrial outer membrane protein that regulates fusion with MiD51 (Fig. 6, G and H) , undergo AS.
Splicing differences between WT and Srpk3-cKO MZ B cells, regardless of stimulation, suggest that SRPK3 fine tunes AS events in MZ B cells.
Similar to mutant immature B cells, we expected to detect the enrichment of SR protein target motifs near exons that were more included in Srpk3-cKO MZ B cells. We observed enrichment of GCAG motifs downstream of included exons in Srpk3-cKO naïve MZ B cells ( Fig. 6I) . Conversely, GCAG motifs were less frequent downstream of exons whose inclusion decreased in Srpk3-cKO naïve MZ B cells. Control motifs that were matched for GC and CpG content were not similarly enriched. We did not observe a similar motif enrichment in the 8-hour stimulated Srpk3-cKO MZ B cells, perhaps due to down-regulation of SRPK3 activity following stimulation (Fig. 6J) .
Mitochondrial dynamics and metabolism are disrupted in splenic B cells that lack SRPK3
Notably, AS of genes that function in mitochondrial maintenance and activity has detrimental effects on cellular metabolism (43) . Flow cytometric analysis revealed that naïve and stimulated Srpk3-cKO MZ B cells each have decreased mitochondrial mass compared to WT MZ B cells (this analysis does not consider relative ultrastructural morphology of mitochondria, which may influence the observed decrease in mass) (Fig. 7, A and B) . To determine whether the loss of mass is due to a decline in mitochondrial abundance, we stained cells with Mitotracker Red and enumerated relative numbers of mitochondria per cell in naïve and stimulated samples using high resolution microscopy. Srpk3-cKO naïve MZ B cells exhibited considerably decreased numbers of mitochondria per cell compared to WT cells (Fig. 7C ). However, after stimulation mitochondrial frequencies were relatively similar between WT and Srpk3-cKO cells.
We next determined whether AS of genes involved in mitochondrial function affects mitochondrial metabolism. We performed mitochondrial stress tests and measured oxygen consumption rates (OCR) between WT and Srpk3-cKO MZ B cells. Srpk3-deficient naïve and stimulated cells each had increased mitochondrial respiratory capacity when compared to WT cells (Fig. 7, D and E) . Additionally, the mutant cells had increased non-mitochondrial respiration, which is indicative of decreased mitochondrial function (44) . Together, these data suggest that mitochondrial function is perturbed in the absence of SRPK3.
Discussion
Functions of SRPK3 in B cells have remained elusive. Here, we observed striking effects of the deletion of Srpk3 genes in cKO mice. Numbers of B cell progenitors in Srpk3-cKO mice are reduced significantly. Antibody responses to TI-2 (and to a lesser degree, TD) antigens were greatly reduced, and the strength of B cell responses to the model TI-2 antigen NP-Ficoll was proportional to the dosage of WT Srpk3 alleles: WT>female hemizygous>null mice, suggesting that Srpk3 impacts humoral responses in a dosage/sex-dependent manner.
The molecular basis of SRPK3's regulation of humoral immunity is undoubtedly complex, because deletion of Srpk3 genes in B cells results in hundreds of different AS events. These results were expected because SRPK family kinases control AS in multiple cell types (reviewed in (9) . We linked AS in immature, mature and MZ B cells with functions including cell signaling and metabolism. The majority of AS events involved SE and MXE, which can result in alternative protein isoforms or promote instability of mRNA and nonsense-mediated decay. In B cells, we propose that SRPK3 regulates SR proteins that direct exon inclusion and skipping (45, 46) . We observed the enrichment of RNA sequence motifs that are often bound by SR proteins in sequences surrounding SRPK3-sensitive exons, arguing that at least some of the alternative splicing outcomes in Srpk3-cKO cells are due to altered regulation of SR proteins.
Immature B cells represent a key checkpoint in BM B cell development. Reduced numbers of these cells and skewed k/l ratios suggest that SRPK3 is involved in generation of the B cell repertoire (47) (48) (49) . Despite clues to the overall functions of SRPK3, the mechanism that reduces BM progenitors in the absence of SRPK3 is unknown. Mutant immature B cells include higher frequencies of Igk + cells, suggesting that either the Igl loci do not rearrange as efficiently or BCR signaling (and in turn, receptor editing) is impaired in cells lacking SRPK3. Additionally, changes in signaling pathways important for immature B cell development were noted, including the ATM kinase, which orchestrates cellular DSB and DDR responses (50, 51) and is critical in regulating V(D)J recombination (52) . Other pathways included modulators of metabolism and mitochondria. In mature B cells, the ERK5 signaling pathway, which is indispensable for BAFFinduced mature B cell survival and self-reactivity, was affected (53, 54) , as well as the mechanistic target of rapamycin (mTOR) and transforming growth factor (TGF)-b signaling pathways (55, 56) . Together, the large number of affected pathways suggests compound effects of mutant proteomes in the absence of SRPK3.
A major conclusion of our studies is that SRPK3 is required for robust humoral responses of B cells in vivo and in vitro. Although the lack of SRPK3 in peripheral B cell subsets did not affect their numbers in unimmunized mice, antibody production (i.e. IgG3) in response to challenge with the TI-2 antigen NP-Ficoll was depressed in male and female null Srpk3-cKO mice. Production of IgG3 in response to TI-2 antigens is a primary role of MZ cells, which are pre-activated to respond to antigens on circulating bacteria in the spleen (57, 58) . MZ B cells undergo CSR preferentially to the IgG3 isotype, which facilitates discrimination of multivalent antigenic targets (59, 60) . The multivalent antigen NP-Ficoll primarily elicits a l + -anti-NP antibody response by MZ (and also by B1) B cells. Decreased l + cells in Srpk3-cKO mice may, in part, explain the deficit in TI-2 responses of these mice. While we have not examined antibody responses to pathogens, we hypothesize that loss of SRPK3 in mice and humans affects the ability to respond to and clear infection.
Many of SRPK3-regulated transcripts encode proteins with functions in cellular metabolism or in the maintenance or biogenesis of mitochondria. In this regard, recent studies confirmed the importance of metabolic reprogramming as a 'gatekeeper' of B lymphocyte development, activation and responses (61) (62) (63) (64) (65) . Loss of SRPK3 in MZ B cells results in differential splicing of candidate gatekeepers Nnt and Slc1a5. Nnt is essential for non-mitochondrial respiration, with important roles in pyruvate metabolism and the Tricarboxylic Acid cycle (TCA) (66) . In turn, the TCA cycle requires glutamine, which is transported by the Slc1a5 solute carrier. Additionally, we observed reduced mitochondrial mass in the absence of SRPK3, which could be due to the differential splicing of Mief1 and Mief2 transcripts encoding the mitochondrial remodeling factors MiD49/51. MiD49/51 helps recruit essential factors like Drp1 to mitochondria to regulate mitochondrial fission (41) . Changes in splicing of metabolic genes results in mitochondrial dysfunction, as evidenced by increased OCR in SRPK3-deficient cells. Bioenergetically disrupted mitochondria require higher levels of ATP for maintaining organelle integrity, which increases the basal oxygen consumption rate (42, 44, 67) . These patterns of high basal OCR and increased glycolysis resemble those in aging cells, which may indicate that the loss of SRPK proteins (e.g. SRPK1) contributes to metabolic shifts observed in aging (68) .
In summary, we propose that SRPK3 is an integral component of splicing pathways in multiple peripheral B cell compartments. Moreover, SRPK3 likely has similar functions in human B cells. A pediatric male patient carrying the mutation I446S in his single SRPK3 allele is reported to have hypogammaglobulinemia, poor responses to vaccines, and frequent ear/sinus and viral infections in addition to expected muscle weakness (MyGene2; (33), while his mother is 'nearly asymptomatic'. These reports suggest important phenotypes relative to dosage of SRPK3. Finally, while SRPK1 and SRPK2 have been studied in human cancers (69), roles of SRPK3 and its importance as a biomarker have not been determined. Additional studies are needed to expand our understanding of SRPK3 functions in normal immunity and effects of its dysregulation in human immunodeficiencies and cancer.
Materials and Methods:
Study Design
The overall goal of these studies was to understand SRPK3's biological roles in B lymphocyte development and function. This was accomplished by specifically ablating Srpk3 genes using Cre-Lox technology in B lineage cells in vivo and monitoring B lymphocyte development, activation and function as a regulator of pre-mRNA splicing. The observed molecular and cellular changes in B cell function due to the loss of SRPK3 was the basis for conclusions drawn.
Animals
All mice were maintained on the C57BL/6N genetic background. The Srpk3-floxed mice were obtained from KOMP Repository (Davis, CA). The Cd79a-Cre Tg/+ mice (21) were kindly provided by John Cambier (University of Colorado, Aurora). Genotyping of Srpk3 and the Cd79a-Cre transgene was performed using tail DNA, PCR and primers as described previously (70) (Table S1 ). All experiments used age-matched male or female test and control littermate mice (6-8 week old). WT littermate controls included mice of the following genotypes: 
